Ikarian Capital, LLC - 31 Dec 2024 SCHEDULE 13G Report for Channel Therapeutics Corp Common Stock, par value $0.0001 per share (CHRO)

Filing Manager: Ikarian Capital, LLC
Reporting Manager: Ikarian Capital, LLC
Security: Channel Therapeutics Corp Common Stock, par value $0.0001 per share
Symbol: CHRO
Shares outstanding: 6,039,027 shares
Disclosed Ownership: 440,849 shares
Ownership: 7.3%
Form type: SCHEDULE 13G
Filing time: 14 Feb 2025, 13:09:03 UTC
Date of event: 31 Dec 2024
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Ikarian Capital, LLC	7.3%	440,849	0	440,849	/s/ Neil Shahrestani	Neil Shahrestani, Sole Manager
Neil Shahrestani	7.3%	440,849	0	440,849	/s/ Neil Shahrestani	Neil Shahrestani